Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0206754|neuroendocrine tumors |
Sentences | 8 |
PubMedID- 25565142 | Biallelic inactivation of men1 encoding menin in pancreatic neuroendocrine tumors (pnets) associated with the multiple endocrine neoplasia type 1 (men1) syndrome is well established, but how menin loss/inactivation initiates tumorigenesis is not well understood. |
PubMedID- 23093487 | Objective: the aim of the study was to determine whether there is an association of abo blood type with the development of neuroendocrine tumors in patients with multiple endocrine neoplasia, type 1 (men-1). |
PubMedID- 26113081 | Objective: the prevalence and clinical behavior of bronchopulmonary neuroendocrine tumors (bnet) associated with multiple endocrine neoplasia type 1 (men1) are not well defined. |
PubMedID- 25713781 | Management of pancreatic neuroendocrine tumors in patients with men 1. |
PubMedID- 23569534 | Gastrinoma and insulinoma are the 2 most common functional pancreatic neuroendocrine tumors in patients with men1 [7]. |
PubMedID- 19960369 | Further evaluation of the captem regimen in patients with pituitary neuroendocrine tumors which fail to respond to classic treatments is warranted. |
PubMedID- 25440487 | Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1. |
PubMedID- 21455335 | Aim: to search for the optimal surgery for gastrinoma and duodenopancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1. |
Page: 1